References
1 Hasegawa J, Suzuki N. SMI for imaging of placental infarction. Placenta. 2016;47:96-8.
2 Hasegawa J, Kurasaki A, Hata T, Homma C, Miura A, Kondo H, et al. Diagnosis of placenta accreta spectrum using ultra-high-frequency probe and Superb Microvascular Imaging. Ultrasound Obstet Gynecol. 2019;54:705-7.
3 Furuya N, Hasegawa J, Homma C, Kawahara T, Iwahata Y, Iwahata H, et al. Novel ultrasound assessment of placental pathological function using superb microvascular imaging. J Matern Fetal Neonatal Med. 2020:1-4.
4 Hata T, Tanaka H, Noguchi J, Hata K. Three-dimensional ultrasound evaluation of the placenta. Placenta. 2011;32:105-15.
5 von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143-8.
6 Arakaki T, Hasegawa J, Nakamura M, Takita H, Hamada S, Oba T, et al. First-trimester measurements of the three-dimensional ultrasound placental volume and uterine artery Doppler in early- and late-onset fetal growth restriction. J Matern Fetal Neonatal Med. 2020;33:564-9.
7 Amy Heerema-McKenney EP, Monique De Paepe. Diagnostic Pathology: Placenta. 2nd ed; 2018.
8 Ernst LM. Maternal vascular malperfusion of the placental bed. Apmis. 2018;126:551-60.
9 Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol. 2018;218:S745-s61.
10 Redline RW, Ravishankar S. Fetal vascular malperfusion, an update. APMIS. 2018;126:561-9.
11 Stanek J. Chorangiosis of Chorionic Villi: What Does It Really Mean? Arch Pathol Lab Med. 2016;140:588-93.
12 Altshuler G. Chorangiosis. An important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med. 1984;108:71-4.
Conflict of Interest: There are no conflicts of interest to declare.